121 related articles for article (PubMed ID: 17139836)
1. [Efficiency of anti-inflammatory therapy for experimental tuberculosis in genetically tuberculosis-sensitive mice].
Kondrat'eva TK; Rubakova EI; Evstifeev VV; Sosunov VV; Petrovskaia SN; Kondrat'eva AV; Apt AS
Probl Tuberk Bolezn Legk; 2006; (10):63-5. PubMed ID: 17139836
[TBL] [Abstract][Full Text] [Related]
2. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
Dutta NK; Mazumdar K; Dastidar SG; Park JH
Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic effect of the anti-inflammatory drug diclofenac in experimental schistosomiasis mansoni.
Nessim NG; Mahmoud S
Int J Infect Dis; 2007 Mar; 11(2):161-5. PubMed ID: 16765078
[TBL] [Abstract][Full Text] [Related]
5. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model.
Radaeva TV; Kondratieva EV; Sosunov VV; Majorov KB; Apt A
Tuberculosis (Edinb); 2008 Nov; 88(6):576-85. PubMed ID: 18667358
[TBL] [Abstract][Full Text] [Related]
6. [Development of the intratracheal infection model of experimental murine mycobacteriosis: comparison with the intravenous infection model].
Doi N
Kekkaku; 1998 May; 73(5):339-47. PubMed ID: 9637818
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological analysis of anti-inflammatory effects of low-intensity extremely high-frequency electromagnetic radiation].
Gapeev AB; Lushnikov KV; Shumilina IuV; Chemeris NK
Biofizika; 2006; 51(6):1055-68. PubMed ID: 17175917
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
[TBL] [Abstract][Full Text] [Related]
9. [Effect of use of bone marrow cells in therapy for experimental tuberculosis].
Pospelov LE; Isaev AA; Bocharova IV; Avdienko VG; Babaian SS; Pospelov AL; Guseva AN; Gergert VIa
Probl Tuberk Bolezn Legk; 2006; (10):60-3. PubMed ID: 17139835
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Byrne ST; Denkin SM; Zhang Y
J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
[TBL] [Abstract][Full Text] [Related]
11. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
Dutta NK; Kumar KA; Mazumdar K; Dastidar SG
Indian J Exp Biol; 2004 Sep; 42(9):922-7. PubMed ID: 15462188
[TBL] [Abstract][Full Text] [Related]
13. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis.
Carlos D; de Souza Júnior DA; de Paula L; Jamur MC; Oliver C; Ramos SG; Silva CL; Faccioli LH
J Infect Dis; 2007 Nov; 196(9):1361-8. PubMed ID: 17922401
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous nociceptive behaviour in female mice with Freund's complete adjuvant- and carrageenan-induced monoarthritis.
Heilborn U; Berge OG; Arborelius L; Brodin E
Brain Res; 2007 Apr; 1143():143-9. PubMed ID: 17316576
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
Barañano DE; Kim SJ; Edelhauser HF; Durairaj C; Kompella UB; Handa JT
Br J Ophthalmol; 2009 Oct; 93(10):1387-90. PubMed ID: 19628498
[TBL] [Abstract][Full Text] [Related]
16. [Impact of M. tuberculosis genotype on survival in mice with experimental tuberculosis].
Andreevskaia SN; Chernousova LN; Smirnova TG; Larionova EE; Kuz'min AV
Probl Tuberk Bolezn Legk; 2007; (7):45-50. PubMed ID: 17718073
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Anti-tuberculosis drug therapy in mice of different inbred strains.
Nikonenko BV; Einck L; Nacy CA
Infect Genet Evol; 2010 Oct; 10(7):1151-4. PubMed ID: 20655396
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of the quantitative intratracheal infection model of experimental murine mycobacteriosis].
Doi N
Kekkaku; 1999 Feb; 74(2):121-4. PubMed ID: 10191605
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence.
Dambuza I; Allie N; Fick L; Johnston N; Fremond C; Mitchell J; Quesniaux VF; Ryffel B; Jacobs M
Tuberculosis (Edinb); 2008 May; 88(3):221-34. PubMed ID: 17950671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
